US Stock MarketDetailed Quotes

Axsome Therapeutics (AXSM)

Watchlist

235.320
+11.290+5.04%

Close May 13 16:00 ET

12.11BMarket Cap-63.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Axsome Therapeutics (AXSM) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

52.28%-20.7M

27.26%-93.41M

28.81%-18.65M

105.61%1.05M

-7.68%-32.42M

18.88%-43.38M

11.49%-128.41M

13.70%-26.2M

65.21%-18.63M

45.60%-30.11M

Net income from continuing operations

-8.63%-64.54M

36.22%-183.17M

61.88%-28.56M

26.89%-47.23M

39.54%-47.97M

13.08%-59.41M

-20.05%-287.22M

24.06%-74.91M

-3.86%-64.6M

-18.13%-79.35M

Operating gains losses

----

--10.39M

--0

----

Depreciation and amortization

10.97%2.37M

13.90%9.06M

9.70%2.27M

16.98%2.41M

12.69%2.25M

16.49%2.13M

16.45%7.96M

19.14%2.07M

18.24%2.06M

18.00%1.99M

Other non cash items

32.04%985K

-102.86%-909K

-169.79%-8.27M

-18.84%13.98M

-347.10%-7.36M

330.25%746K

-40.24%31.73M

-73.19%11.85M

1,572.14%17.22M

-59.95%2.98M

Change In working capital

268.02%17.05M

-166.44%-22.52M

-153.33%-6.83M

74.72%8.78M

-162.63%-14.33M

-49.10%-10.15M

219.40%33.9M

273.69%12.8M

156.09%5.03M

272.97%22.88M

-Change in receivables

-37.13%-26.6M

-74.78%-82.46M

-56.14%-27.96M

161.75%2.32M

-97.96%-37.43M

-193.21%-19.4M

17.40%-47.18M

-9.14%-17.91M

65.89%-3.75M

16.40%-18.91M

-Change in inventory

-304.65%-4.87M

-542.48%-15.67M

15.74%-3.49M

-422.63%-6.93M

-866.10%-4.05M

-23.87%-1.2M

45.34%-2.44M

-130.81%-4.14M

-23.45%2.15M

150.19%528K

-Change in prepaid assets

-145.02%-9.87M

56.69%-1.67M

328.33%6.14M

-115.28%-3.45M

-247.77%-331K

-2.86%-4.03M

27.59%-3.86M

208.81%1.43M

-80.52%-1.6M

131.55%224K

-Change in payables and accrued expense

303.27%58.39M

-11.56%77.28M

-44.68%18.48M

104.54%16.85M

-33.05%27.47M

208.28%14.48M

126.82%87.38M

45.65%33.41M

6,488.80%8.24M

268.00%41.04M

Cash from discontinued investing activities

Operating cash flow

52.28%-20.7M

27.26%-93.41M

28.81%-18.65M

105.61%1.05M

-7.68%-32.42M

18.88%-43.38M

11.49%-128.41M

13.70%-26.2M

65.21%-18.63M

45.60%-30.11M

Investing cash flow

Cash flow from continuing investing activities

64.20%-121K

-77.78%-480K

-136.67%-71K

35.56%-58K

75.00%-13K

-244.90%-338K

53.61%-270K

-328.57%-30K

75.74%-90K

60.90%-52K

Net PPE purchase and sale

64.20%-121K

-77.78%-480K

-136.67%-71K

35.56%-58K

75.00%-13K

-244.90%-338K

53.61%-270K

-328.57%-30K

75.74%-90K

60.90%-52K

Net business purchase and sale

----

--0

----

Cash from discontinued investing activities

Investing cash flow

64.20%-121K

-77.78%-480K

-136.67%-71K

35.56%-58K

75.00%-13K

-244.90%-338K

53.61%-270K

-328.57%-30K

75.74%-90K

60.90%-52K

Financing cash flow

Cash flow from continuing financing activities

-89.77%2.99M

75.42%101.47M

15.03%16.39M

-30.05%21.27M

140.24%34.54M

2,565.88%29.27M

-82.53%57.84M

712,300.00%14.24M

-8.89%30.41M

-94.16%14.38M

Net issuance payments of debt

-67.58%-672K

-315.35%-4.11M

-63.94%-541K

-113.50%-664K

-1,247.31%-2.51M

-146.01%-401K

-101.16%-990K

---330K

---311K

-100.62%-186K

Net common stock issuance

-67.72%6.34M

66.50%67.9M

-65.44%5.68M

-24.08%9.95M

189.71%32.63M

--19.65M

-84.24%40.78M

--16.42M

-61.18%13.1M

--11.26M

Proceeds from stock option exercised by employees

-41.41%9.98M

94.13%59.56M

1,236.06%15.34M

-23.49%15.52M

72.99%11.66M

581.13%17.04M

147.04%30.68M

0.26%1.15M

370.00%20.29M

2.60%6.74M

Net other financing activities

-80.47%-12.66M

-73.22%-21.89M

-36.55%-4.09M

-32.26%-3.54M

-110.58%-7.25M

-98.98%-7.01M

49.78%-12.63M

-160.94%-2.99M

43.05%-2.68M

77.79%-3.44M

Cash from discontinued financing activities

Financing cash flow

-89.77%2.99M

75.42%101.47M

15.03%16.39M

-30.05%21.27M

140.24%34.54M

2,565.88%29.27M

-82.53%57.84M

712,300.00%14.24M

-8.89%30.41M

-94.16%14.38M

Net cash flow

Beginning cash position

2.40%322.93M

-18.34%315.35M

-0.63%325.27M

-4.00%303.02M

-9.21%300.91M

-18.34%315.35M

92.29%386.19M

-21.42%327.34M

-27.79%315.66M

34.45%331.44M

Current changes in cash

-23.43%-17.83M

110.70%7.58M

80.49%-2.34M

90.48%22.26M

113.34%2.11M

73.62%-14.44M

-138.22%-70.84M

60.53%-11.99M

156.86%11.68M

-108.28%-15.78M

End cash Position

1.39%305.11M

2.40%322.93M

-0.63%325.27M

-4.00%303.02M

-9.21%300.91M

-18.34%315.35M

-21.42%327.34M

-27.79%315.66M

Free cash flow

52.37%-20.82M

27.04%-93.89M

28.62%-18.72M

105.28%988K

-7.54%-32.44M

18.39%-43.71M

11.66%-128.68M

13.62%-26.23M

65.28%-18.72M

45.64%-30.16M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	52.28%-20.7M	27.26%-93.41M	28.81%-18.65M	105.61%1.05M	-7.68%-32.42M	18.88%-43.38M	11.49%-128.41M	13.70%-26.2M	65.21%-18.63M	45.60%-30.11M
Net income from continuing operations	-8.63%-64.54M	36.22%-183.17M	61.88%-28.56M	26.89%-47.23M	39.54%-47.97M	13.08%-59.41M	-20.05%-287.22M	24.06%-74.91M	-3.86%-64.6M	-18.13%-79.35M
Operating gains losses	----	--10.39M	--0	--0	----	----	----	----	----	----
Depreciation and amortization	10.97%2.37M	13.90%9.06M	9.70%2.27M	16.98%2.41M	12.69%2.25M	16.49%2.13M	16.45%7.96M	19.14%2.07M	18.24%2.06M	18.00%1.99M
Other non cash items	32.04%985K	-102.86%-909K	-169.79%-8.27M	-18.84%13.98M	-347.10%-7.36M	330.25%746K	-40.24%31.73M	-73.19%11.85M	1,572.14%17.22M	-59.95%2.98M
Change In working capital	268.02%17.05M	-166.44%-22.52M	-153.33%-6.83M	74.72%8.78M	-162.63%-14.33M	-49.10%-10.15M	219.40%33.9M	273.69%12.8M	156.09%5.03M	272.97%22.88M
-Change in receivables	-37.13%-26.6M	-74.78%-82.46M	-56.14%-27.96M	161.75%2.32M	-97.96%-37.43M	-193.21%-19.4M	17.40%-47.18M	-9.14%-17.91M	65.89%-3.75M	16.40%-18.91M
-Change in inventory	-304.65%-4.87M	-542.48%-15.67M	15.74%-3.49M	-422.63%-6.93M	-866.10%-4.05M	-23.87%-1.2M	45.34%-2.44M	-130.81%-4.14M	-23.45%2.15M	150.19%528K
-Change in prepaid assets	-145.02%-9.87M	56.69%-1.67M	328.33%6.14M	-115.28%-3.45M	-247.77%-331K	-2.86%-4.03M	27.59%-3.86M	208.81%1.43M	-80.52%-1.6M	131.55%224K
-Change in payables and accrued expense	303.27%58.39M	-11.56%77.28M	-44.68%18.48M	104.54%16.85M	-33.05%27.47M	208.28%14.48M	126.82%87.38M	45.65%33.41M	6,488.80%8.24M	268.00%41.04M
Cash from discontinued investing activities
Operating cash flow	52.28%-20.7M	27.26%-93.41M	28.81%-18.65M	105.61%1.05M	-7.68%-32.42M	18.88%-43.38M	11.49%-128.41M	13.70%-26.2M	65.21%-18.63M	45.60%-30.11M
Investing cash flow
Cash flow from continuing investing activities	64.20%-121K	-77.78%-480K	-136.67%-71K	35.56%-58K	75.00%-13K	-244.90%-338K	53.61%-270K	-328.57%-30K	75.74%-90K	60.90%-52K
Net PPE purchase and sale	64.20%-121K	-77.78%-480K	-136.67%-71K	35.56%-58K	75.00%-13K	-244.90%-338K	53.61%-270K	-328.57%-30K	75.74%-90K	60.90%-52K
Net business purchase and sale	----	----	----	----	----	----	--0	----	----	----
Cash from discontinued investing activities
Investing cash flow	64.20%-121K	-77.78%-480K	-136.67%-71K	35.56%-58K	75.00%-13K	-244.90%-338K	53.61%-270K	-328.57%-30K	75.74%-90K	60.90%-52K
Financing cash flow
Cash flow from continuing financing activities	-89.77%2.99M	75.42%101.47M	15.03%16.39M	-30.05%21.27M	140.24%34.54M	2,565.88%29.27M	-82.53%57.84M	712,300.00%14.24M	-8.89%30.41M	-94.16%14.38M
Net issuance payments of debt	-67.58%-672K	-315.35%-4.11M	-63.94%-541K	-113.50%-664K	-1,247.31%-2.51M	-146.01%-401K	-101.16%-990K	---330K	---311K	-100.62%-186K
Net common stock issuance	-67.72%6.34M	66.50%67.9M	-65.44%5.68M	-24.08%9.95M	189.71%32.63M	--19.65M	-84.24%40.78M	--16.42M	-61.18%13.1M	--11.26M
Proceeds from stock option exercised by employees	-41.41%9.98M	94.13%59.56M	1,236.06%15.34M	-23.49%15.52M	72.99%11.66M	581.13%17.04M	147.04%30.68M	0.26%1.15M	370.00%20.29M	2.60%6.74M
Net other financing activities	-80.47%-12.66M	-73.22%-21.89M	-36.55%-4.09M	-32.26%-3.54M	-110.58%-7.25M	-98.98%-7.01M	49.78%-12.63M	-160.94%-2.99M	43.05%-2.68M	77.79%-3.44M
Cash from discontinued financing activities
Financing cash flow	-89.77%2.99M	75.42%101.47M	15.03%16.39M	-30.05%21.27M	140.24%34.54M	2,565.88%29.27M	-82.53%57.84M	712,300.00%14.24M	-8.89%30.41M	-94.16%14.38M
Net cash flow
Beginning cash position	2.40%322.93M	-18.34%315.35M	-0.63%325.27M	-4.00%303.02M	-9.21%300.91M	-18.34%315.35M	92.29%386.19M	-21.42%327.34M	-27.79%315.66M	34.45%331.44M
Current changes in cash	-23.43%-17.83M	110.70%7.58M	80.49%-2.34M	90.48%22.26M	113.34%2.11M	73.62%-14.44M	-138.22%-70.84M	60.53%-11.99M	156.86%11.68M	-108.28%-15.78M
End cash Position	1.39%305.11M	2.40%322.93M	2.40%322.93M	-0.63%325.27M	-4.00%303.02M	-9.21%300.91M	-18.34%315.35M	-18.34%315.35M	-21.42%327.34M	-27.79%315.66M
Free cash flow	52.37%-20.82M	27.04%-93.89M	28.62%-18.72M	105.28%988K	-7.54%-32.44M	18.39%-43.71M	11.66%-128.68M	13.62%-26.23M	65.28%-18.72M	45.64%-30.16M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm